Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        FDA Newsroom

FDA Insight Home
          News & Events
          FDA Newsroom
          FDA InsightFDA Newsroom FDA Insight
  	
        Share
    Post
    Linkedin

    Email
    PrintDecorative cover art for the FDA Insight podcast
 Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics.

**The program will be on hiatus starting Jan. 20, 2021.**

Ep. #
			Title and Link to Transcript
			Link to Podcast
			Runtime01
			**Fighting COVID-19 at the FDA**

			FDA Commissioner Dr. Stephen Hahn, and FDA Deputy Commissioner for Medical and Scientific Affairs Dr. Anand Shah discuss FDA's COVID-19 efforts, including the drug development process for a COVID-19 treatment.
			Listen (MP3, 13MB)
			13:4002
			**All About COVID-19 Testing**

			Dr. Anand Shah, FDA’s Deputy Commissioner for Medical and Scientific Affairs, welcomes Toby Lowe, the Associate Director of the Office of In Vitro Diagnostics and Radiological Health, to discuss the basics of diagnostic tests for COVID-19.
			Listen (MP3, 9MB)
			09:3803
			**Food Safety and COVID-19**

			FDA Commissioner Stephen M. Hahn, M.D., returns to FDA Insight to discuss food safety issues during the COVID-19 pandemic.
			Listen (MP3, 10MB)
			11:1704
			**Clinical Trials and Treatments for COVID-19**

			Dr. Patrizia Cavazzoni, the acting director of FDA’s Center for Drug Evaluation and Research, joins Dr. Shah for an in-depth discussion on clinical trials and treatments for COVID-19. A list of clinical trials are available at https://clinicaltrials.gov.
			Listen (MP3, 15MB)
			15:5805
			**Vaccines for COVID-19, Part 1**

			In Part 1 of FDA Insight’s vaccine series, Dr. Shah welcomes Dr. Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, to discuss the basics of COVID-19 vaccine development.
			Listen (MP3, 11MB)
			11:4106
			**Vaccines for COVID-19, Part 2**

			Dr. Peter Marks returns for a more comprehensive discussion on vaccines as they relate to COVID-19. Find out more about “herd immunity,” Operation Warp Speed, and vaccine distribution in this episode.
			Listen (MP3, 14MB)
			15:4507
			**A “Topical” Discussion on Sunscreen**

			During the summer, fun in the sun is a high priority for many families, but what do you really know about that sunscreen protecting you? Dr. Terri Michele, the Director of the Office of Non-Prescription Drugs in FDA’s Center for Drug Evaluation and Research, joins Dr. Shah to discuss sunscreen safety.
			Listen (MP3, 10MB)
			11:0008
			**Your Digital Health**

			Dr. Shah welcomes Bakul Patel, the director of Digital Health at FDA’s Center for Devices and Radiological Health, to discuss telemedicine, digital health tools, and FDA’s new Digital Health Center of Excellence.
			Listen (MP3, 11MB)
			12:2209
			**Health Fraud and COVID-19**

			Dr. Judy McMeekin, the Associate Commissioner for Regulatory Affairs, joins Dr. Shah on the show to discuss FDA's fight against health fraud during the COVID-19 pandemic.
			Listen (MP3, 6MB)
			06:0810
			**Drug Shortages and COVID-19**

			Valerie Jensen, the Associate Director of the Drug Shortages staff in FDA's Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on drug shortages and how the COVID-19 pandemic can impact the drug supply chain.
			Listen (MP3, 9MB)
			09:1711
			**The Opioid Epidemic and COVID-19 Pandemic**

			Dr. Shah welcomes Megan Moncur, FDA’s Associate Director of Opioid Policy, to the show to discuss the opioid epidemic and how it’s been impacted by the COVID-19 pandemic.
			Listen (MP3, 20MB)
			21:2312
			**E-Cigarettes and the National Youth Tobacco Survey**

			Mitch Zeller, Director of FDA's Center for Tobacco Products, joins Dr. Shah in a discussion on e-cigarettes (or vapes) and the 2020 National Youth Tobacco Survey results. For more on how you can stop using tobacco products, go to https://everytrycounts.gov.
			Listen (MP3, 18MB)
			20:0013
			**A Closer Look at Nutrition**

			Dr. Shah welcomes Dr. Susan Mayne, Director of FDA's Center for Food Safety and Applied Nutrition, to discuss nutrition and chronic disease prevention, including health disparities.
			Listen (MP3, 17MB)
			18:5014
			**Anti-Microbial Resistance**

			Dr. Shah welcomes Dr. Steve Solomon, Director of FDA's Center for Veterinary Medicine, to discuss the work CVM is doing in combating antimicrobial resistance.
			Listen (MP3, 12MB)
			13:1515
			**An Insight into Women’s Health**

			Dr. Kaveeta Vasisht, FDA's Associate Commissioner for Women's Health, joins FDA Insight to discuss the Office of Women's Health's work to advance the health of women through scientific programs, policy development, research, education and outreach.
			Listen (MP3, 14MB)
			14:5516
			**Advisory Committee on COVID-19 Vaccines**

			Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and Related Biological Products Advisory Committee meeting.
			Listen (MP3, 9MB)
			09:3917
			**Get Your Flu Vaccine**

			On this week's episode, Dr. Shah brings Dr. Peter Marks back to the show to discuss the importance of getting the flu vaccine. For more information about the flu vaccine, visit: https://www.fda.gov/flu
			Listen (MP3, 13MB)
			14:0018
			**Hand Hygiene During COVID-19**

			Dr. Shah welcomes Elizabeth Jungman, director of CDER’s Office of Regulatory Policy, to talk about hand sanitizers and the COVID-19 pandemic.
			Listen (MP3, 11MB)
			11:5419
			**Personal Protective Equipment and COVID-19**

			Dr. Shah welcomes Dr. Suzanne Schwartz, director of FDA’s Office of Strategic Partnerships and Technology Innovation at the Center for Devices and Radiological Health, for a discussion on personal protective equipment and its critical role in helping to reduce the spread of COVID-19.
			Listen (MP3, 16MB)
			17:2420
			**Rare Diseases and Orphan Products**

			Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluation and development of products that demonstrate promise for the diagnosis and treatment of rare diseases.
			Listen (MP3, 14MB)
			15:0021
			**Minority Health and Health Equity**

			Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations.
			Listen (MP3, 12MB)
			13:2522
			**Advanced Manufacturing**

			Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on how FDA’s efforts help innovation and implementation of Advanced Manufacturing technologies regarding food and drug safety.
			Listen (MP3, 10MB)
			11:1823
			**Compounded Drugs**

			Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.
			Listen (MP3, 10MB)
			10:5724
			**New Era of Smarter Food Safety**

			Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s COVID-19 response.
			Listen (MP3, 18MB)
			19:3125
			**Pandemic Recovery and Preparedness Plan (PREPP)**

			Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA Insight as they discuss FDA’s Pandemic Recovery and Preparedness Plan, or PREPP. After this episode, the program is scheduled to go on hiatus.
			Listen (MP3, 11MB)
			11:54

RSS

                                                                                  Content current as of:
      01/19/2021FDA Insight
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop